type stringclasses 2
values | gt_table stringlengths 116 12.6k | image imagewidth (px) 109 761 |
|---|---|---|
complex | <table><tr><td>Effects and limitations of management contract</td><td>Public sector perspective</td><td>private sector perspective</td></tr><tr><td rowspan="5">Effects</td><td>By introducing competitive forces, contracting puts pressure on both public and private providers in terms of both service and price.</td><td>Co... | |
simple | <table><tr><td></td><td>No. herds</td><td>End of one year study period</td><td>Herd size Cow years/year</td><td>Calculated bulk tank somatic cell count</td><td>Milk production Kg ECM/day</td><td>Mastitis treatments % cows treated/cow year</td><td>% of cows with infection risk > 50%</td></tr><tr><td>Conventional</td>... | |
complex | <table><tr><td rowspan="3">History of blood donation</td><td colspan="2">Blood donation total attitude</td><td rowspan="3"><i>P</i> value<sup>*</sup></td></tr><tr><td colspan="2">score (4–20)</td></tr><tr><td>Median</td><td>Mean rank</td></tr><tr><td>Yes</td><td>16.5</td><td>196.0</td><td rowspan="2"><0.001</t... | |
simple | <table><tr><td>Sample ID</td><td>MW of standard protein bands (KDa)</td></tr><tr><td><i>C. muytjensii</i>ATCC 51329</td><td>66, 80 & 150</td></tr><tr><td><i>C. sakazakii</i>ATCC 29544</td><td>66, 125</td></tr><tr><td>MP04.1</td><td>66 & 80</td></tr><tr><td>MP08.5</td><td>66, 80,125 & 150</td></tr><tr><td>MP... | |
simple | <table><tr><td></td><td>Cumulated Dose (μGy) @ 0.152 m</td><td>Cumulated Dose (μGy) @ 0.305 m</td><td>Cumulated Dose (μGy) @ 0.914 m</td></tr><tr><td>1 hr</td><td>87.3</td><td>56.0</td><td>9.9</td></tr><tr><td>2 hr</td><td>147.0</td><td>94.3</td><td>16.6</td></tr><tr><td>3 hr</td><td>188.0</td><td>120.6<... | |
complex | <table><tr><td colspan="6">Percentage of 13-to 17-Year-OldGirls Completing HPV Vaccine Series, U.S., 2012</td></tr><tr><td>Range</td><td>State</td><td>Percent</td><td>Range</td><td>State</td><td>Percent</td></tr><tr><td>≥50%</td><td>Rhode Island</td><td>57.7</td><td></td><td>Kentucky</td><td>34.9</td></tr><tr><td... | |
simple | <table><tr><td>Diagnosis</td><td>Tumour biopsy</td><td>Perilesional skin</td><td>Total</td></tr><tr><td> </td><td>No. of positive/total (%)</td><td>No. of positive/total (%)</td><td>No. of positive/total (%)</td></tr><tr><td>BCC</td><td>31/50 (62)</td><td>24/50 (48)</td><td>55/100 (55)</td></tr><tr><td>SCC</td><td>8/9 ... | |
complex | <table><tr><td rowspan="2">Approach</td><td colspan="10">Number of Links</td></tr><tr><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td><td>All</td></tr><tr><td>ELM</td><td>2.8596</td><td>2.2980</td><td>2.8878</td><td>3.5223</td><td>2.5630</td><td>2.7815</td><td>2.7059</td><td>3... | |
complex | <table><tr><td rowspan="2">PAH</td><td rowspan="2">TEF</td><td>Surgeon</td><td> </td><td>AT</td><td> </td></tr><tr><td>PAH<sub>Gas</sub></td><td>PAH<sub>Particle</sub></td><td>PAH<sub>Gas</sub></td><td>PAH<sub>Particle</sub></td></tr><tr><td>Naphthalene</td><td>0.001</td><td>1055</td><td>1.6</td><td>584</td><td>1.1</td... | |
complex | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Category</td><td colspan="2">Fresh samples <i>n</i> (%)</td><td rowspan="2">Paraffin-embedded samples <i>n</i> (%)</td></tr><tr><td>Non-metastatic</td><td>Metastatic</td></tr><tr><td>Age</td><td>< 50 year</td><td>5 (50)</td><td>2 (20)</td><td>8 (15.4)</td></tr>... | |
complex | <table><tr><td>Enrichment Categories</td><td><i>p</i>-Value</td><td>FDR</td><td>Related Genes</td></tr><tr><td colspan="4">GO processes</td></tr><tr><td>Negative regulation of eicosanoid secretion</td><td>7.5 × 10<sup>−9</sup></td><td>3.0 × 10<sup>−6</sup></td><td>Hrh2, F2rl2</td></tr><tr><td>Gluc... | |
simple | <table><tr><td>Organism</td><td><1 mo</td><td>1-11 mos</td><td>1-55 yrs</td><td>6-12 yrs</td><td>> 12 yrs</td><td>Age Unk</td><td>Total</td><td>% of total</td></tr><tr><td>Streptococcus pneumoniae</td><td>2</td><td>31</td><td>27</td><td>17</td><td>87</td><td>42</td><td>187</td><td>37.18</td></tr><tr><td>Neisseria... | |
complex | <table><tr><td>Ecological</td><td></td><td colspan="3">Levels</td><td colspan="3">Change in change</td></tr><tr><td>Model</td><td>Dependent variable</td><td>PCNSDP</td><td>PCDE</td><td>HCR</td><td>PCNSDP</td><td>PCDE</td><td>HCR</td></tr><tr><td rowspan="2">1</td><td rowspan="2">Stunting prevalence</td><td>−1.92*... | |
simple | <table><tr><td>ID</td><td>Annotation</td><td>290 vs. 5532 fold change</td><td>290 vs. 5532 – <i>p</i>-value corrected FDR</td><td>Normalized expression means 290</td><td>Normalized expression means 5532</td></tr><tr><td>APOBEC3A</td><td>Probable DNA dC- > dU-editing enzyme APOBEC-3A</td><td>1.80E+308</td><td>0... | |
simple | <table><tr><td>TRT</td><td>Day 10-PC</td><td>Day 23-PC</td><td>Day 28-PC</td><td>Day 36-PC</td><td>Day 50-PC</td><td>Day 10-Stx 1</td><td>Day 10-Stx 2</td><td>Day 10-eae</td><td>Day 23-Stx 1</td><td>Day 23-Stx 2</td><td>Day 23-eae</td><td>Day 28-Stx 1</td><td>Day 28-Stx 2</td><td>Day 28-eae</td></tr><tr><td>Sb1/2e</td>... | |
complex | <table><tr><td>Follow-up periods</td><td colspan="6"><i>P </i>value for lab data</td></tr><tr><td></td><td>Hemoglobin</td><td>TLC</td><td>Platelets</td><td>Bilirubin</td><td>ALT</td><td>AST</td></tr><tr><td>Before therapy versus after 1 month</td><td>0.00</td><td>0.78</td><td>0.19</td><td>0.00</td><td>0.00</td><td>0.00... | |
complex | <table><tr><td>Dependent Variable:</td><td colspan="3">Mal_Tot</td><td></td><td colspan="3">Mal_Tot</td><td></td></tr><tr><td>Type of Model</td><td>PRM</td><td></td><td>NBRM</td><td></td><td>PRM</td><td></td><td>NBRM</td><td></td></tr><tr><td>Nobs</td><td>47</td><td></td><td>47</td><td></td><td>47</td><td></td><td>47</... | |
simple | <table><tr><td>Species</td><td>GenBank Accession</td><td>Reference</td></tr><tr><td><i>Bathymodiolus azoricus</i></td><td>AF334663</td><td>[70]</td></tr><tr><td><i>B. thermophilus</i></td><td>AF334664</td><td>[70]</td></tr><tr><td><i>Crassostrea virginica 1</i></td><td>AB206328</td><td>[58]</td></tr><tr><td><i>Crassost... | |
simple | <table><tr><td>Day of follow up</td><td>0</td><td>1</td><td>2</td><td>3</td><td>7</td><td>14</td><td>21</td><td>28</td></tr><tr><td>Patients assessed at visit</td><td>176</td><td>173</td><td>172</td><td>172</td><td>172</td><td>171</td><td>171</td><td>171</td></tr><tr><td>Loss to follow up</td><td>0</td><td>3</td><td>1<... | |
simple | <table><tr><td>Term</td><td>MAPP Network Research Definition</td></tr><tr><td>Urologic chronic pelvic pain syndrome (UCPPS)</td><td>General term to describe idiopathic chronic pelvic pain of urologic origin in men or women. In MAPP Network studies, this includes men and women with IC/BPS, or men with CP/CPPS (see below... | |
simple | <table><tr><td>Name of classifier</td><td>MNC</td><td>DNC</td><td>TNC</td><td>IPknot<sup>*</sup></td><td>IPknot<sup>#</sup></td></tr><tr><td>BayesNet</td><td>0.073</td><td>0.084</td><td>0.284</td><td>-</td><td>0.397</td></tr><tr><td>NaiveBayes</td><td>0.057</td><td>0.074</td><td>0.058</td><td>0.315</td><td>0.398</td></... | |
complex | <table><tr><td>Dose</td><td>Direction</td><td>Striatum</td><td>Hippocampus</td><td>Cortex</td></tr><tr><td rowspan="2">10 mg/kg</td><td>Up in YAC128, Down with pridopidine</td><td>3.58E-04</td><td>3.78E-04</td><td>2.40E-04</td></tr><tr><td>Down in YAC128, Up with pridopidine</td><td>3.64E-04</td><td>4.99E-02</td><td>2.... | |
complex | <table><tr><td rowspan="2">Saccade Behavior</td><td rowspan="2">Leading Vehicle</td><td colspan="5">Speed (km/h)</td></tr><tr><td>60</td><td>70</td><td>80</td><td>90</td><td>100</td></tr><tr><td rowspan="2">Mean saccade duration (ms)</td><td>Truck</td><td>46.21</td><td>55.92</td><td>58.55</td><td>65.89</td><td>102.51</... | |
simple | <table><tr><td>Number</td><td>Age (years)</td><td>Sex</td><td>Primary hematological disorder</td><td>Organs involved by tuberculosis</td><td>Diagnosis of tuberculosis</td><td>Treatment/Outcome of tuberculosis</td></tr><tr><td>1</td><td>55</td><td>Male</td><td>Chronic myeloid leukemia</td><td>Intestine, mesentry and abd... | |
complex | <table><tr><td rowspan="2">Clinical parameter</td><td colspan="2">AFAP1‐AS1</td><td rowspan="2">Chi‐squared test P value</td></tr><tr><td>High no. cases</td><td>Low no. cases</td></tr><tr><td>Age (years)</td><td></td><td></td><td>0.449</td></tr><tr><td>≤64</td><td>25</td><td>12</td><td></td></tr><tr><... | |
simple | <table><tr><td>Imprecision</td><td>Event</td><td>Original Text</td><td>English Translation</td></tr><tr><td></td><td>Basel, Jul. 1480</td><td>“Anno 1480 circa Magdalenae ingens fuit aquarum inundatio. Rhenus in tantum crevit, quod ad lateres usque inferioris muri Minoris Basileae circa litus ascendit. Etiam homin... | |
simple | <table><tr><td> </td><td>n</td><td>Minimum</td><td>Maximum</td><td>Mean</td><td>Std Deviation</td></tr><tr><td>Age (months)</td><td>20</td><td>6.00</td><td>59.00</td><td>39.3500</td><td>18.65</td></tr><tr><td>Weight (Kg)</td><td>20</td><td>6.7</td><td>23.4</td><td>14.9</td><td>4.5</td></tr><tr><td>Temp(<sup>0</sup>C)</... | |
complex | <table><tr><td></td><td></td><td colspan="3">Low prescribers (<i>n</i> = 408)</td><td colspan="3">High prescribers (<i>n</i> = 408)</td></tr><tr><td></td><td></td><td>Number</td><td>Percent</td><td>[95% confidence interval]</td><td>Number</td><td>Percent</td><td>[95% confidence interval]</td></tr><tr><td rowspan="2">Ge... | |
complex | <table><tr><td>Prognostic factor</td><td>N</td><td>Dead over 5 years (%)</td><td>Hazard ratio (95 % CI)</td><td>p</td></tr><tr><td><i>Model-1</i></td><td></td><td></td><td></td><td></td></tr><tr><td>CD8 response to Her-2</td><td></td><td></td><td>0.198 (0.05–1.17)</td><td><i>0.018</i></td></tr><tr><td> Yes</td><t... | |
simple | <table><tr><td> </td><td>Total group (n = 1,304)</td><td>No sexual violence (n = 806)</td><td>Rape (n = 183)</td><td>Non-consensual sex (n = 315)</td><td><i>F/χ</i><sup><i>2</i></sup></td></tr><tr><td>Age<sup>†</sup></td><td>15.89 (1.54)</td><td>15.73 (1.49)</td><td>16.34 (1.51)</td><td>16.04 (1.63)</td><td>... | |
complex | <table><tr><td>Item</td><td></td><td>N</td><td colspan="2">Time 1 (Pre)</td><td colspan="2">Time 3 (6 Month)</td><td colspan="2">Mean change*</td><td>P value*</td></tr><tr><td></td><td></td><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>95% CI</td><td></td></tr><tr><td>1</td><td>I am confiden... | |
complex | <table><tr><td>Author, year</td><td>Study population (period)</td><td>Definition of HDP-related SAMM</td><td>Case fatality rate (Number of deaths/cases)</td><td colspan="2">Mortality reduction<sup>a</sup></td></tr><tr><td></td><td></td><td></td><td></td><td colspan="2">Natural case fatality</td></tr><tr><td></td><td></... | |
simple | <table><tr><td>Characteristic</td><td>Number of patients(%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Female</td><td>318 (29.1)</td></tr><tr><td>Male</td><td>775 (70.9)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td>Median</td><td></td></tr><tr><td>(range)</td><td>47 (15-90)</td></tr><tr><td>≤ 47</td... | |
complex | <table><tr><td>Group</td><td>Quintile</td><td colspan="2">Total PA</td><td colspan="2">Moderate PA</td><td colspan="2">Vigorous PA</td><td colspan="2">MVPA</td></tr><tr><td> </td><td> </td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td></tr><tr><td colspan="10">B... | |
simple | <table><tr><td>Parameter</td><td>Benign (n = 102)</td><td>Malignant (n = 11)</td><td>P value</td></tr><tr><td>Age</td><td>58.9 ± 16.4</td><td>48.8 ± 18.7</td><td>0.059</td></tr><tr><td>Female gender</td><td>66 (64.7)</td><td>5 (45.5)</td><td>0.209</td></tr><tr><td>Urgent intervention</td><td>22 (21.6)</td><td... | |
simple | <table><tr><td>Hospital</td><td>Case (male/female)</td><td>Percentage of total</td></tr><tr><td>Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine</td><td>178 (111/67)</td><td>5.03%</td></tr><tr><td>Guanganmen Hospital affiliated to China Academy of Chinese Medical Science</td><td>564 (363/201)</t... | |
complex | <table><tr><td>Cluster of Life Sciences</td><td>BMBS - Biomedicine and Molecular BiosciencesFA - Food and AgricultureFPS - Forests, their Products and Services</td></tr><tr><td>Cluster of Natural Sciences</td><td>CMST - Chemistry and Molecular Sciences and TechnologiesESSEM - Earth System Science and Environmental Mana... | |
simple | <table><tr><td>Chronic Disease (outcome variables)</td><td>Frequent mental distress (FMD) Beta (SE)<sup>1</sup></td><td>Obesity Beta (SE)<sup>1</sup></td></tr><tr><td>Diabetes</td><td>0.55 (0.03)<sup>2</sup></td><td>1.17 (0.02)<sup>2</sup></td></tr><tr><td>High Blood Pressure</td><td>0.54 (0.02)<sup>2</sup></td><td>0.9... | |
simple | <table><tr><td>Factor</td><td>Factor level</td><td>Frequency (n)</td><td>Percentage</td><td>Chi-square</td><td>df</td><td>Significance</td></tr><tr><td>Habitat stability</td><td>Permanent</td><td>214</td><td>63.13</td><td></td><td></td><td></td></tr><tr><td></td><td>Temporary</td><td>125</td><td>36.87</td><td>22.317</t... | |
simple | <table><tr><td></td><td>Combined SMI group (n = 230)</td><td>Glasgow City (n = 8,094)</td><td>P<sup>1</sup></td><td>Scotland (n = 54,590)</td><td>P<sup>2</sup></td></tr><tr><td>Cause of death (n, %)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cerebrovascular disease</td><td>8 (3.5%)</td><td>304 (3.8%)... | |
complex | <table><tr><td>Haplotype</td><td>Freq (case)</td><td>Freq (control)</td><td><i>P</i></td><td>OR (95% CI)</td></tr><tr><td colspan="5">rs12068264|rs11576175</td></tr><tr><td> CA</td><td>0.1685 (61)</td><td>0.203 (82)</td><td></td><td>1.000 (Reference)</td></tr><tr><td> TG</td><td>0.4088 (149)</td><td>0.3416 (139)</td><t... | |
complex | <table><tr><td rowspan="2">Compounds</td><td rowspan="2">pIC<sub>50</sub></td><td colspan="2">CoMFA</td><td colspan="2">CoMSIA</td><td colspan="2">HQSAR</td></tr><tr><td>Pred.</td><td>Res.</td><td>Pred.</td><td>Res.</td><td>Pred.</td><td>Res.</td></tr><tr><td>1</td><td>4.1</td><td>4.078</td><td>0.022</td><td>4.331</td>... | |
simple | <table><tr><td>Demographic characteristics</td><td>Value</td></tr><tr><td>Age in years, mean (range)</td><td>55.9 (42 to 79)</td></tr><tr><td>Race, <i>n</i> (%)</td><td></td></tr><tr><td>White</td><td>4 (50)</td></tr><tr><td>African heritage</td><td>2 (25)</td></tr><tr><td>Asian - Japanese/East Asian/Southeast Asian he... | |
simple | <table><tr><td>Trial</td><td>Hb (g/L)</td><td>Ferritin (<i>μ</i>g/L)</td><td>TSAT (%)</td><td>BM iron</td></tr><tr><td>Auerbach 2004 [26]</td><td>≤105</td><td>≤200</td><td>≤19*</td><td> ND</td></tr><tr><td>Auerbach 2010 [31]</td><td>≤100</td><td>≥10</td><td>≥15</td><td> ND</td><... | |
simple | <table><tr><td>Kidney tissue</td><td>Treatment</td><td>1 h</td><td>24 h</td><td>48 h</td><td>72 h</td></tr><tr><td>Cortex</td><td>CG</td><td>19.0 ± 2.3</td><td>18.9 ± 2.1</td><td>19.2 ± 2.2</td><td>18.9 ± 2.7</td></tr><tr><td> </td><td>DN PC</td><td>24.5 ± 3.6*</td><td>24.5 ± 4.3*</td><td>... | |
complex | <table><tr><td rowspan="2"></td><td>Healthy volunteers</td><td>ObT2D</td><td>HV/ObT2D</td></tr><tr><td>(n = 19)</td><td>(n = 20)</td><td>p value</td></tr><tr><td>Intra-myocardium dixon fat fraction (%)</td><td>7.9 ± 3.7</td><td>6.0 ± 1.5</td><td></td></tr><tr><td>Dixon 3D epicardial fat volume (mL)</td><td>17... | |
complex | <table><tr><td rowspan="2">Name</td><td rowspan="2">Chr</td><td rowspan="2">Bins<sup>a</sup></td><td colspan="2">QTL confidence interval, bp</td><td rowspan="2">LOD<sup>b</sup></td><td rowspan="2">R<sup>2</sup></td><td rowspan="2">Additive Effect<sup>c</sup></td></tr><tr><td>Left border</td><td>Right border</td></tr><t... | |
complex | <table><tr><td colspan="8">Stage 1: selection of study sites</td></tr><tr><td>Region</td><td>Country</td><td>Estimated no. ART clinics (yr. of assessment)</td><td>Estimated no. adult ART enrollees at ART clinics</td><td>No. eligible clinics*</td><td>Estimated no. study-eligible adult ART enrollees at eligible clinics</... | |
complex | <table><tr><td>CT technique description</td><td colspan="2">Injection activity (MBq)</td><td colspan="2">Effective dose (mSv)</td><td colspan="2">Effective dose per unit activity (mSv/MBq)</td></tr><tr><td></td><td>Male</td><td>Female</td><td>Male</td><td>Female</td><td>Male</td><td>Female</td></tr><tr><td>Standard CT<... | |
simple | <table><tr><td>Gene Ontology<sup>a</sup></td><td>DAVID<sup>b</sup></td></tr><tr><td>Biological process</td><td></td></tr><tr><td> Cell adhesion (GO:0007155)</td><td>0.0000148</td></tr><tr><td> Cell communication</td><td>0.000632</td></tr><tr><td>G-protein signaling, coupled to cyclic nucleotide second messenger</td><td... | |
complex | <table><tr><td rowspan="2">Outcome and instrument</td><td rowspan="2">Method</td><td colspan="3">Data collection time</td></tr><tr><td>T0</td><td>T1</td><td>T2</td></tr><tr><td>Perceived health</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>SF-36</td><td>Interview caregiver or mailed questionnaire</td><td>x</... | |
simple | <table><tr><td>Strategy</td><td>Treatment</td><td>Genomic Profile</td><td>Phase</td><td>N</td><td>ORR (%)</td><td>PFS (M)</td><td>OS (M)</td><td>Clinical Development</td><td>Reference</td></tr><tr><td>BRAF monotherapy</td><td>Vemurafenib</td><td>BRAFmut</td><td>I/II</td><td>21</td><td>5</td><td>2.1</td><td>7.7</td><td>... | |
complex | <table><tr><td>Dose level</td><td>N</td><td colspan="3">Radiation therapy dose (Gy)</td><td>Dose delay due to AE</td></tr><tr><td>Level 1</td><td>3</td><td>62</td><td>62<sup>a</sup></td><td>64</td><td>1 (3 days)</td></tr><tr><td rowspan="2">Level 2</td><td>6</td><td>64</td><td>60</td><td>62</td><td rowspan="2">0</td></... | |
complex | <table><tr><td>Socio -demographic Characteristic</td><td>Number</td><td>%</td></tr><tr><td colspan="3">Age (in years)</td></tr><tr><td> 15–34</td><td>109</td><td>25.6</td></tr><tr><td> 25–34</td><td>166</td><td>39.1</td></tr><tr><td> 35–44</td><td>150</td><td>35.3</td></tr><tr><td colspan="3">Ethnicit... | |
simple | <table><tr><td>IR score</td><td>A II(<i>n</i> = 6)</td><td>A III(<i>n</i> = 12)</td><td>GBM (<i>n</i> = 55 )</td><td>Control cortex/autopsy (<i>n</i> = 8)</td><td>Control cortex/surgical (<i>n</i> = 5)</td></tr><tr><td>Kir4.1</td><td>3.6 ± 0.85*</td><td>7.18 ± 0.41</td><td>5.5 ± 0.30</td><td>7.13 ± ... | |
complex | <table><tr><td>Category</td><td>Characteristic</td><td>Comparison</td><td>Pre-campaign</td><td>Mid-campaign</td><td>Post-campaign</td></tr><tr><td rowspan="5">Demographics</td><td rowspan="4">Child’s age (months)</td><td>12–23 vs. 0–11</td><td>1.40 (0.98, 2.01)</td><td>1.13 (0.50, 2.57)</td><td>1.07 (... | |
simple | <table><tr><td>Assay</td><td></td><td>Primer Sequence 5’-3’</td></tr><tr><td><underline>Pyrosequencing</underline></td><td></td><td></td></tr><tr><td>Assay 1 (20 CpGs)</td><td>Forward</td><td>GGATGTGGGGATTTTTTTTTTTTAGTATAG</td></tr><tr><td></td><td>Reverse</td><td>Biotin-ACTTCAACCCCTCCCCCAAAA</td></tr><tr><... | |
complex | <table><tr><td rowspan="2">Riparian metric</td><td colspan="2">Mean annual rainfall</td><td colspan="2">Mean annual temperature</td><td colspan="2">Bank height</td><td colspan="2">Proportion of clay</td></tr><tr><td>Estimate</td><td>SE</td><td>Estimate</td><td>SE</td><td>Estimate</td><td>SE</td><td>Estimate</td><td>SE<... | |
simple | <table><tr><td> </td><td><i>O. scapulalis</i></td><td><i>O. nubilalis</i></td></tr><tr><td>Raw short sequence number</td><td>322,504</td><td>307,622</td></tr><tr><td>Number after filtering</td><td>287,429</td><td>272,490</td></tr><tr><td>Mean read length (bp)</td><td>352</td><td>356</td></tr><tr><td>Number of singleton... | |
simple | <table><tr><td></td><td>Total</td><td>Men</td><td>Women</td></tr><tr><td>Camp (n = 538)</td><td>37.8%</td><td>42.7%</td><td>34%</td></tr><tr><td>Somali (n = 248)</td><td>48.1%</td><td>48.1%</td><td>48.1%</td></tr><tr><td>Rwandese (n = 290)</td><td>32%</td><td>38.9%</td><td>27.3%</td></tr></table> | |
simple | <table><tr><td>Study [reference]: countries</td><td>Population</td><td><i>n</i></td><td>Efficacy</td><td>Lower bound of 95% CI</td><td>Adherence<sup>a</sup></td></tr><tr><td>Partners PrEP [8]: Kenya, Uganda</td><td>Heterosexual couples</td><td>4758</td><td>67% TDF; 75% TDF/FTC</td><td>44% TDF; 55% TDF/FTC</td><td>82%</... | |
simple | <table><tr><td>Risk factor</td><td>Crude OR</td><td>Adjusted OR<sup>a</sup></td></tr><tr><td>Own preterm birth<sup>b</sup></td><td>2.10 (1.27–3.48)</td><td>2.32 (1.34–4.03)</td></tr><tr><td>PCOS</td><td>1.44 (1.05–1.97)</td><td>1.07 (0.74–1.54)</td></tr><tr><td>BMI ≥25 kg/m<sup>2</sup></td... | |
simple | <table><tr><td></td><td>PANSS positive subscale score</td><td>PANSS negative subscale score</td><td>PANSS general psychopathology subscale score</td><td>PANSS total score</td></tr><tr><td>Serum S100B level changes</td><td>r=0.3P=0.2</td><td>r=-0.048P=0.8</td><td>r=0.05P=0.8</td><td>r=0.06P=0.7</td></tr><tr><td>Leptin (... | |
complex | <table><tr><td>SH3 domain</td><td>k<sub>a </sub>(M<sup>-1</sup>s<sup>-1</sup>) × 10<sup>5</sup></td><td>k<sub>d </sub>(s<sup>-1</sup>) × 10<sup>-2</sup></td><td>K<sub>D </sub>(μM)</td><td>Nef concentrations (μM)</td></tr><tr><td colspan="5">Nef-SF2</td></tr><tr><td>Human Hck SH3</td><td>1.60 ± ... | |
complex | <table><tr><td></td><td colspan="2">Run 1</td><td colspan="2">Run 2</td><td colspan="2">Summary</td></tr><tr><td>HRM</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td> Number of samples</td><td>120</td><td>100.0</td><td>20</td><td>100.0 (16.7)</td><td>120</td><td>100.0</td></tr><tr><td> Analy... | |
simple | <table><tr><td>URL structure</td><td>Get</td><td>Post</td><td>Delete</td></tr><tr><td>/namespace/object_type/</td><td>List objects, apply filters</td><td>Create new object or make bulk update</td><td>Bulk delete</td></tr><tr><td>/namespace/object_type/id/</td><td>Access single object</td><td>Update single object</td><t... | |
complex | <table><tr><td rowspan="2">Parameters</td><td colspan="4">Groups</td><td colspan="3"><i>p</i>values</td></tr><tr><td>Control</td><td>Control + Ucche</td><td>CCl<sub>4</sub></td><td>CCl<sub>4</sub> + Ucche</td><td>CCl<sub>4</sub></td><td>Treatment</td><td>Interaction</td></tr><tr><td colspan="5">Plasma</td><td></td><td>... | |
complex | <table><tr><td rowspan="2"></td><td></td><td>Gender</td><td></td></tr><tr><td>Female</td><td>Male</td><td>Total</td></tr><tr><td colspan="4">Need for treatment</td></tr><tr><td> Discussed and confirmed<sup>a</sup></td><td>17</td><td>36</td><td>53</td></tr><tr><td> Discussed, not confirmed</td><td>0</td><td>0</td><td>0<... | |
complex | <table><tr><td colspan="2">RTI/STI symptomatic currently or within last 3 months</td><td>n = 353</td><td>%</td></tr><tr><td>Sought care for RTI/STI symptoms</td><td></td><td></td><td></td></tr><tr><td> Yes</td><td></td><td>238</td><td>67.4</td></tr><tr><td> No</td><td></td><td>115</td><td>32.6</td></tr><tr><td>Time del... | |
simple | <table><tr><td>Compound</td><td>IC<sub>50</sub> [μM]</td><td>log P</td></tr><tr><td>2a</td><td>≥100</td><td>3.32</td></tr><tr><td>2b</td><td>58</td><td>3.48</td></tr><tr><td>2c</td><td>≥100</td><td>3.88</td></tr><tr><td>2d</td><td>≥100</td><td>3.81</td></tr><tr><td>3a</td><td>49</td><td>3.89</td>... | |
simple | <table><tr><td> </td><td>LBD alone (<i>n</i> = 62)</td><td>EST plus LBD (<i>n</i> = 69)</td><td><i>P </i>value</td></tr><tr><td>Diameter of inflated balloon (mm)</td><td>15.9 ± 2.3 (12-20)</td><td>16.2 ± 2.5 (12-20)</td><td>0.444</td></tr><tr><td>Complete stone removal irrespective of whether ML was used, no.... | |
simple | <table><tr><td>Disease class</td><td>Nt</td><td>Nur</td><td>F<sub>IC</sub></td></tr><tr><td>Gastrointestinal</td><td>17</td><td>145</td><td>0.88</td></tr><tr><td>Respiratory</td><td>5</td><td>15</td><td>0.71</td></tr><tr><td>Wound healing</td><td>2</td><td>3</td><td>0.50</td></tr><tr><td>Dermatological</td><td>1</td><t... | |
simple | <table><tr><td>Phenotype</td><td>n</td><td>CaseAverageRelatedness</td><td>MeanControlAverageRelatedness</td><td>Empiricalp-valueGIF</td><td>Empiricalp-valueDistantGIF</td></tr><tr><td>CFS</td><td>811</td><td>3.15</td><td>2.31</td><td>< 0.001</td><td>0.010</td></tr></table> | |
simple | <table><tr><td>Variable</td><td>1<sup>st</sup> quarterN (%)</td><td>2<sup>nd</sup> quarterN (%)</td><td>3<sup>rd</sup> quarter(N%)</td><td>4<sup>th</sup> quarter(N%)</td><td>TotalN (%)</td><td>P value</td></tr><tr><td>Age(years)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>≤ 15</td><td>2... | |
simple | <table><tr><td> </td><td> </td><td> </td><td>Normal PI</td><td>Low PI</td></tr><tr><td>Restricted growth parameters</td><td>Subclass of SGA</td><td>N</td><td>no (%)</td><td>no (%)</td></tr><tr><td>Weight, length and OFC</td><td>Symmetrical</td><td>1</td><td>1 (100.0)</td><td>0 (0.0)</td></tr><tr><td>Weight and length a... | |
complex | <table><tr><td rowspan="2">Amino acid substituted in Y114</td><td colspan="2">37 °C</td><td colspan="2">65 °C<sup>a</sup></td></tr><tr><td>Isomerase activity (mM/min μg)</td><td>Epimerase activity (mM/min μg)</td><td>Isomerase activity (mM/min μg)</td><td>Epimerase activity (mM/min μg)</td... | |
simple | <table><tr><td>References</td><td>Primary outcomes</td><td>Secondary outcomes</td></tr><tr><td>Song (weak)<sup>1</sup>[44]</td><td>Recalled stocking and sales scores were higher in intervention stores than in control stores.</td><td>There was improvement in some specific mediator factors but not in overall mediator fac... | |
simple | <table><tr><td></td><td>Tree 1</td><td>Tree 2</td><td>Tree 3</td><td>Pfam</td></tr><tr><td>Average sequence identity</td><td>19%</td><td>30%</td><td>42%</td><td>-</td></tr><tr><td>Alignment length</td><td>1080</td><td>629</td><td>597</td><td>404</td></tr><tr><td>Sequence length</td><td>173</td><td>177</td><td>169</td><... | |
complex | <table><tr><td><i>Expression level</i></td><td colspan="3"><i>Overall survival</i></td></tr><tr><td> </td><td><i>Median survival (95% CI, months)</i></td><td><i>Log-rank P</i></td><td><i>HR (95% CI)</i></td></tr><tr><td>Low ERCC1</td><td>11.7(2.6-15.3)</td><td>-</td><td>-</td></tr><tr><td>High ERCC1</td><td>17.4(4.3-22... | |
simple | <table><tr><td>Compounds</td><td>KB <sup>b</sup></td><td>A549 <sup>b</sup></td><td>Compounds</td><td>KB <sup>b</sup></td><td>A549 <sup>b</sup></td></tr><tr><td>Etoposide <sup>c</sup></td><td>0.85 ± 0.08</td><td>0.99 ± 0.09</td><td>C5</td><td>2.45 ± 0.41</td><td>5.24 ± 1.12</td></tr><tr><td>T2</td><t... | |
simple | <table><tr><td>Baseline</td><td>Pre App</td><td>App</td><td>Post App</td></tr><tr><td>Complete DASS-21</td><td>Rate subjective wellbeing and distress daily for 7 days</td><td>Rate subjective wellbeing and distress daily for 7 days</td><td>Complete DASS-21</td></tr><tr><td></td><td>Complete DASS-21 after 7 days</td><td>... | |
simple | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Maximum data rate</td><td>250 kbps</td></tr><tr><td>Discovery packet time</td><td>10 s</td></tr><tr><td>Transmission power</td><td>0 dBm</td></tr><tr><td>Receiver sensitivity</td><td>−85 dBm</td></tr><tr><td>Average frame length</td><td>22 Bytes</td></tr><tr... | |
simple | <table><tr><td>Primers and probes</td><td>Gene sequence</td></tr><tr><td>GAPDH sense</td><td>TGCACCACCAACTGCTTAG</td></tr><tr><td>GAPDH antisense</td><td>GGATGCAGGGATGATGTTC</td></tr><tr><td>GAPDH probe</td><td>CAGAAGACTGTGGATGGCCCCTC</td></tr><tr><td>IL-1β sense</td><td>TCCTGAACTCAACTGTGAAATGC</td></tr><tr><td>IL... | |
complex | <table><tr><td></td><td colspan="4">Mother</td><td colspan="4">Newborn</td></tr><tr><td></td><td colspan="3">DNA</td><td>Serum<sup>3</sup></td><td colspan="3">DNA</td><td>Serum<sup>3</sup></td></tr><tr><td></td><td>Cervical</td><td>Oral<sup>5</sup></td><td>Cervical/Oral</td><td></td><td>Genital</td><td>Oral</td><td>Gen... | |
simple | <table><tr><td></td><td></td><td>Baseline</td><td>Reexamination</td></tr><tr><td></td><td>N</td><td>27</td><td>25</td></tr><tr><td></td><td>Mean dmft ± SD</td><td>5.1 ± 1.8</td><td>8.8 ± 0.7</td></tr><tr><td>ECC stages</td><td>Initial stage (N, %)</td><td>(27) 100%</td><td>(0) 0%</td></tr><tr><td></td><t... | |
complex | <table><tr><td>Characteristic</td><td>Total population<sup><i>a</i></sup> [<i>n</i> (%)]</td><td>No tree canopy (%)</td><td> ≥50% impervious surface (%)</td><td>Both conditions (%)</td></tr><tr><td>Total population</td><td>81,517,417 (100.0)</td><td>42.1</td><td>62.2</td><td>36.5</td></tr><tr><td>Metro area segre... | |
simple | <table><tr><td><i>Number (%) of </i></td><td>Pre-eclamptic (<i>N </i>= 143)</td><td>Controls(<i>N </i>= 143)</td><td><i>P</i></td></tr><tr><td>Primigravidae</td><td>49(34.3)</td><td>27(18.9)</td><td>0.01</td></tr><tr><td>lack of antenatal care</td><td>21(14.7)</td><td>33(23.1)</td><td>0.02</td></tr><tr><td>Educational ... | |
simple | <table><tr><td> </td><td>Am Δ</td><td>Cm Δ</td><td>Cf Δ</td><td> </td><td>Am Λ</td><td>Cm Λ</td><td>Cf Λ</td></tr><tr><td>O13</td><td>2.472 (3)</td><td>2.462 (3)</td><td>2.455 (4)</td><td>O1</td><td>2.507 (3)</td><td>2.496 (3)</td><td>2.476 (4)</td></tr><tr><td>O14</td><td>2.491 (3)</td><t... | |
complex | <table><tr><td>Test</td><td>Cutoff for “abnormal”</td><td>All Stages (<i>N</i> = 5731)</td><td>Stage 1 (<i>N</i> = 4058)</td><td>Stage 2 (<i>N</i> = 981)</td><td>Stage 3 (<i>N</i> = 692)</td></tr><tr><td colspan="6">Urine Tests</td></tr><tr><td>Eosinophils</td><td>≥1 %</td><td>6.9</td><td>5.8</td><td>... | |
complex | <table><tr><td>Variable</td><td>Median (25th, 75th percentile)</td></tr><tr><td colspan="2">Sleep</td></tr><tr><td> Time in bed (hours:minutes)</td><td>9:31 (9:02, 9:58)</td></tr><tr><td> Sleep duration (hours:minutes)</td><td>8:29 (7:59, 8:59)</td></tr><tr><td> Sleep midpoint (hours:minutes)</td><td>2:44 (2:14, 3:29)<... | |
simple | <table><tr><td>Pre-SBRT factors</td><td>G4-5 RP</td><td>G0-3 RP</td><td>Total</td><td>X2 test</td><td>1-year cumulative incidence of G4-5 RP</td><td>log-rank</td></tr><tr><td>Serum KL-6</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>high value</td><td>6</td><td>17</td><td>23</td><td><i>p </i>= 0... | |
complex | <table><tr><td></td><td colspan="6">Cross-section 2004</td><td>Panel 2002–2004</td></tr><tr><td>Variable</td><td>Average for treated</td><td>Average for untreated</td><td>Single difference in averages</td><td>% difference</td><td>Boot-strapped Std. Err.</td><td>P-value</td><td>Double differences/differences-in-di... | |
simple | <table><tr><td>Variables</td><td>No. of patientsn(%)</td><td>Western medicinen(%)</td><td>Chinese medicine n(%)</td><td><i>P</i>-value</td></tr><tr><td>Total</td><td>786(100)</td><td>337(42.9)</td><td>449(57.1)</td><td></td></tr><tr><td>Conventional treatment</td><td>781(99.4)</td><td>337(100)</td><td>444(98.9)</td><td... | |
simple | <table><tr><td>Strain of <i>C. jejuni</i></td><td>Rate of growth (μ<sub>max</sub>) in microaerobic conditions</td><td>Death times (D-values) in aerobic conditions</td></tr><tr><td>Bf</td><td>0.5763</td><td>\**</td></tr><tr><td>subsp. <i>jejuni</i> NCTC 11168</td><td>0.7714*</td><td>0.9737</td></tr><tr><td>subsp. <... | |
complex | <table><tr><td rowspan="3">Quality-of-care category<sup>a</sup></td><td colspan="6">Summary score</td></tr><tr><td colspan="3">Baseline</td><td colspan="3">End of the study</td></tr><tr><td>Intervention group, mean (SD)</td><td>Control group, mean (SD)</td><td>Intervention versus control group, mean difference (95% CI)... | |
complex | <table><tr><td></td><td colspan="3">SCC</td></tr><tr><td>Herd size</td><td>< = 200</td><td>201-400</td><td>> 400</td></tr><tr><td>Q1</td><td>35.52</td><td>42.35</td><td>22.12</td></tr><tr><td>Q2</td><td>33.06</td><td>46.99</td><td>19.96</td></tr><tr><td>Q3</td><td>31.38</td><td>49.47</td><td>19.15</td></tr><tr><t... | |
simple | <table><tr><td>Level of Adaptation to Heat</td><td>% Who Reported Adverse Health Impacts</td><td>Confidence Interval</td><td>Coeff. of Variation</td><td>Odds Ratio</td><td>Confidence Interval</td><td>Pr > χ<sup>2</sup></td></tr><tr><td>Individuals who adapt well</td><td>45.77</td><td>(41.78–49.76)</td><td... | |
simple | <table><tr><td></td><td>Blood</td><td>Brain</td><td>Liver</td><td>Tongue</td><td>Skin</td><td>Lung</td><td>Muscle</td><td>Intestine</td><td>Tumour</td></tr><tr><td>L-BPA (μg/g)</td><td>13.42 ± 1.26</td><td>4.97 ± 0.54</td><td>12.11 ± 1.82</td><td>13.62 ± 5.15</td><td>15.65 ± 2.77</td><td>1... | |
complex | <table><tr><td></td><td>Kidney</td><td>Kidney pancreas</td></tr><tr><td>Number recruited</td><td>42</td><td>19</td></tr><tr><td>Sex male/female</td><td>31M/11F</td><td>9M/10F</td></tr><tr><td>Median age (range)</td><td>54 (26–74)</td><td>47 (30–59)</td></tr><tr><td colspan="3">Donor type</td></tr><tr><td>Li... | |
complex | <table><tr><td colspan="2">Demographic</td><td>Physicians (n = 13)</td><td>Nursing staff (n = 13)</td><td>Overall (n = 26)</td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td>4</td><td>1</td><td>5</td></tr><tr><td>Female</td><td>9</td><td>12</td><td>21</td></tr><tr><td>Age (yr)</td><td>Mean (range)</td><td>45 (25R... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.